DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation.


Journal

Annual review of pathology
ISSN: 1553-4014
Titre abrégé: Annu Rev Pathol
Pays: United States
ID NLM: 101275111

Informations de publication

Date de publication:
24 01 2020
Historique:
pubmed: 2 11 2019
medline: 30 5 2020
entrez: 2 11 2019
Statut: ppublish

Résumé

Recognizing the importance of leukocyte trafficking in inflammation led to some therapeutic breakthroughs. However, many inflammatory pathologies remain without specific therapy. This review discusses leukocytes in the context of sterile inflammation, a process caused by sterile (non-microbial) molecules, comprising damage-associated molecular patterns (DAMPs). DAMPs bind specific receptors to activate inflammation and start a highly optimized sequence of immune cell recruitment of neutrophils and monocytes to initiate effective tissue repair. When DAMPs are cleared, the recruited leukocytes change from a proinflammatory to a reparative program, a switch that is locally supervised by invariant natural killer T cells. In addition, neutrophils exit the inflammatory site and reverse transmigrate back to the bloodstream. Inflammation persists when the program switch or reverse transmigration fails, or when the coordinated leukocyte effort cannot clear the immunostimulatory molecules. The latter causes inappropriate leukocyte activation, a driver of many pathologies associated with poor lifestyle choices. We discuss lifestyle-associated inflammatory diseases and their corresponding immunostimulatory lifestyle-associated molecular patterns (LAMPs) and distinguish them from DAMPs.

Identifiants

pubmed: 31675482
doi: 10.1146/annurev-pathmechdis-012419-032847
doi:

Substances chimiques

Alarmins 0
Biological Factors 0
Environmental Biomarkers 0
Pathogen-Associated Molecular Pattern Molecules 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

493-518

Auteurs

Joel Zindel (J)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta T2N 4N1, Canada; email: pkubes@ucalgary.ca.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Department of Visceral Surgery and Medicine, Department for BioMedical Research, University of Bern, CH-3008 Bern, Switzerland.
Graduate School for Cellular and Biomedical Sciences, University of Bern, CH-3012 Bern, Switzerland.

Paul Kubes (P)

Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta T2N 4N1, Canada; email: pkubes@ucalgary.ca.
Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH